14-53152762-TGCCGCC-TGCCGCCGCCGCC
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 2P and 16B. PM4BP6_Very_StrongBA1
The NM_001160148.2(DDHD1):c.331_336dupGGCGGC(p.Gly111_Gly112dup) variant causes a conservative inframe insertion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.82 in 1,576,386 control chromosomes in the GnomAD database, including 533,603 homozygotes. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.75 ( 44193 hom., cov: 0)
Exomes 𝑓: 0.83 ( 489410 hom. )
Consequence
DDHD1
NM_001160148.2 conservative_inframe_insertion
NM_001160148.2 conservative_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.972
Publications
7 publications found
Genes affected
DDHD1 (HGNC:19714): (DDHD domain containing 1) This gene is a member of the intracellular phospholipase A1 gene family. The protein encoded by this gene preferentially hydrolyzes phosphatidic acid. It is a cytosolic protein with some mitochondrial localization, and is thought to be involved in the regulation of mitochondrial dynamics. Overexpression of this gene causes fragmentation of the tubular structures in mitochondria, while depletion of the gene results in mitochondrial tubule elongation. Deletion of this gene in male mice caused fertility defects, resulting from disruption in the organization of the mitochondria during spermiogenesis. In humans, mutations in this gene have been associated with hereditary spastic paraplegia (HSP), also known as Strumpell-Lorrain disease, or, familial spastic paraparesis (FSP). This inherited disorder is characterized by progressive weakness and spasticity of the legs. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
PM4
Nonframeshift variant in NON repetitive region in NM_001160148.2.
BP6
Variant 14-53152762-T-TGCCGCC is Benign according to our data. Variant chr14-53152762-T-TGCCGCC is described in ClinVar as Benign. ClinVar VariationId is 221131.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.936 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| DDHD1 | NM_001160148.2 | c.331_336dupGGCGGC | p.Gly111_Gly112dup | conservative_inframe_insertion | Exon 1 of 13 | ENST00000673822.2 | NP_001153620.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| DDHD1 | ENST00000673822.2 | c.331_336dupGGCGGC | p.Gly111_Gly112dup | conservative_inframe_insertion | Exon 1 of 13 | NM_001160148.2 | ENSP00000500986.2 |
Frequencies
GnomAD3 genomes AF: 0.753 AC: 113312AN: 150480Hom.: 44177 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
113312
AN:
150480
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.834 AC: 155876AN: 187002 AF XY: 0.838 show subpopulations
GnomAD2 exomes
AF:
AC:
155876
AN:
187002
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.827 AC: 1179127AN: 1425798Hom.: 489410 Cov.: 111 AF XY: 0.830 AC XY: 586736AN XY: 707038 show subpopulations
GnomAD4 exome
AF:
AC:
1179127
AN:
1425798
Hom.:
Cov.:
111
AF XY:
AC XY:
586736
AN XY:
707038
show subpopulations
African (AFR)
AF:
AC:
16820
AN:
32864
American (AMR)
AF:
AC:
34094
AN:
39232
Ashkenazi Jewish (ASJ)
AF:
AC:
19502
AN:
24972
East Asian (EAS)
AF:
AC:
36180
AN:
38438
South Asian (SAS)
AF:
AC:
72592
AN:
83094
European-Finnish (FIN)
AF:
AC:
40438
AN:
49176
Middle Eastern (MID)
AF:
AC:
3697
AN:
4600
European-Non Finnish (NFE)
AF:
AC:
907961
AN:
1094544
Other (OTH)
AF:
AC:
47843
AN:
58878
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
12995
25989
38984
51978
64973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20760
41520
62280
83040
103800
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.753 AC: 113368AN: 150588Hom.: 44193 Cov.: 0 AF XY: 0.757 AC XY: 55606AN XY: 73504 show subpopulations
GnomAD4 genome
AF:
AC:
113368
AN:
150588
Hom.:
Cov.:
0
AF XY:
AC XY:
55606
AN XY:
73504
show subpopulations
African (AFR)
AF:
AC:
21508
AN:
41006
American (AMR)
AF:
AC:
12596
AN:
15206
Ashkenazi Jewish (ASJ)
AF:
AC:
2748
AN:
3456
East Asian (EAS)
AF:
AC:
4714
AN:
4918
South Asian (SAS)
AF:
AC:
4187
AN:
4762
European-Finnish (FIN)
AF:
AC:
8559
AN:
10434
Middle Eastern (MID)
AF:
AC:
234
AN:
294
European-Non Finnish (NFE)
AF:
AC:
56431
AN:
67518
Other (OTH)
AF:
AC:
1634
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1229
2458
3687
4916
6145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
832
1664
2496
3328
4160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Hereditary spastic paraplegia 28 Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:2
Jun 11, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Mar 04, 2016
GeneDx
Significance:Benign
Review Status:flagged submission
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.